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ABSTRACT
Introduction: The presence of calcifications may be useful for the diagnosis of breast neoplasia.  Objective: 
To determine the association between the characteristics of mammographic calcifications and malignant 
neoplasia. Methods: Observational, analytical, retrospective of cases and controls. Developed in the 
Gynecology Breast Pathology Unit. Female patients with mammogram suggestive of malignant neoplasm 
with a positive malignancy biopsy were included as cases, and 67 patients without histological evidence of 
malignancy as controls. Results: The average age of the cases was 54.12 years, in the controls 50.34. 50,.9% 
(59) are older than or equal to 50 years, OR 2,399 95% CI (1,125-5,114) p = 0.022, of these 52.5% (31) had 
breast cancer. 9.5% (11) had calcifications suspicious of malignancy, the most frequent, the amorphous 
and the pleomorphic fine. 37.1% (43) of the total cases have the BI-RADS 0 category, 6.9% (8) BI-RADS 1, 
8.6% (10) BI-RADS 2, 7.8 % (9) BI-RADS 3, 28.4% (33) BI-RADS 4, 8.6% (10) BI-RADS 5 and 2.6% (3) BI-RADS 6. 
72, 7% (8) of patients with calcifications suspected of malignancy presented breast cancer. In the bivariate 
analysis, an OR of 4,163 was obtained. 95% CI (1,043-16,606) p = 0,031. In the multivariate analysis the 
association remained unchanged regardless of age and BI-RADS. Conclusion: Age 50 years or older and 
mammographic calcifications suspected of malignancy are associated factors for breast cancer.
Key words: Breast cancer; Mammography; Malignant neoplasm. (source: MeSH NLM)
RESUMEN
Introducción: La presencia de calcificaciones puede ser útil para el diagnóstico de neoplasia de mama. 
Objetivo: Determinar la asociación entre las características de las calcificaciones mamográficas y neoplasia 
maligna. Métodos: Estudio observacional, analítico, retrospectivo de casos y controles. Desarrollado 
en la Unidad de Patología Mamaria de ginecología. Se incluyeron como casos a pacientes mujeres con 
mamografía sugerente de neoplasia maligna con biopsia positiva a malignidad y como controles a 67 
pacientes sin evidencia histológica de neoplasia. Resultados: La edad media de los casos fue de 54,12 
años, en los controles 50,34. El 50,9%(59) son mayores o iguales a 50 años, OR 2,399 IC 95% (1,125 – 
5,114) p=0,022, de estos el 52,5% (31) tenían cáncer de mama. El 9,5%(11) presentaron calcificaciones 
sospechosas de malignidad, las más frecuentes, la amorfa y la fina pleomórfica. El 37,1% (43) de los casos 
totales correspondieron a la categoría BI-RADS 0, el 6,9% (8)  a BI-RADS 1, el 8,6% (10) a BI-RADS 2, el 
7,8% (9) a BI-RADS 3, el 28,4% (33)a  BI-RADS 4, el 8,6% (10) a BI-RADS 5 y el 2,6% (3) a BI-RADS 6. El 
72,7% (8) de pacientes con calcificaciones sospechosas de malignidad presentó cáncer de mama. En el 
análisis bivariado se obtuvo un OR de 4,163. IC 95% (1,043 – 16,606) p = 0,031. En el análisis multivariado 
la asociación permaneció inalterada independientemente de la edad y BI-RADS. Conclusión: La edad 
mayor o igual de 50 años y las calcificaciones mamográficas sospechosas de malignidad son factores 
asociados para el cáncer de mama.
Palabras clave: Cáncer de mama; Mamografía; Neoplasia maligna. (fuente: DeCS BIREME)
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Breast cancer is the most common cancer in women 
worldwide(1,2). In Peru, the number of cases ranks 
second in frequency among the neoplasms reported(3).
The breast cancer guide of the National Comprehensive 
Cancer Network (NCCN), states that mammography 
and physical examination are the tools that enable 
breast cancer screening, in other words, the 
identification of the nosological entity(4). Screening 
detects the breast cancer cases early and makes it 
possible to cure it.
The task of the radiologist is to identify the 
mammographic characteristics that have positive 
predictive value for malignancy and to translate this 
percentage to an international scale called Breast 
Imaging Reporting and Data System (BI-RADS).
Industrialized countries reduce the breast cancer 
mortality rate by 2.2% per year by screening and early 
treatment(4). However, in Peru, the lack of specialized 
equipment and the lack of a culture of prevention do 
not allow the establishment of an effective national 
screening program, which implies that cancer is 
detected in late stages, reducing its chances of healing(5).
The purpose of this work is to generate knowledge so 
that the imaging support allows the identification of 
lesions with positive predictive value to malignancy in 
the Peruvian population.
METHODS
We conducted an observational, analytical, 
retrospective study of cases and controls female patients 
with mammography and anatomopathological 
diagnosis treated at the Breast Pathology Unit of 
the Hipolito Unanue Hospital in 2017. We reviewed 
the clinical histories of 46 female patients (cases) 
with mammography suggestive to malignancy with 
biopsy positive to malignancy and 67 (controls) with 
mammography suggestive to malignancy with biopsy 
negative to malignancy. The cases were defined as 
those patients with diagnosis of breast cancer; while 
controls were those with diagnosis not corresponding 
to malignancy. Four potentially associated variables 
were evaluated: age at risk, calcifications suspected 
of malignancy, breast composition and BI-RADS 
categories.
Numerical variables were presented as mean or 
median and standard deviation or interquartile range 
according to their distribution. Categorical variables 
were presented as frequencies and percentages. 
Crude and adjusted odds ratios were obtained using 
multiple logistic regression to evaluate the association 
of the type of calcifications with the presence of 
neoplasia demonstrated histologically.
RESULTS
We included a total of 116 patients who had 
mammography and anatomopathological report 
performed in the hospitalization of Hipolito Unanue 
during 2017. From the total population, 57.2% (67) 
did not develop breast cancer and 42.2% (49) were 
diagnosed with breast cancer, of this group 49.1% 
(57) were under 50 years and 50.9% (59) were the 
same age or over 50 years. Calcifications suspected of 
malignancy were present in 9.5% (11) of patients.



















Figure 1 shows two boxes. The box of breast cancer 
patients is more variable than the box of patients 
without breast cancer. Both boxes and whiskers are 
asymmetrical to the right. The minimum and maximum 
age values for cancer patients are 29 and 73 respectively. 
The median age of these patients was 54 years with 
an interquartile range of 45.5 to 64 years. For patients 
without cancer, age ranged from 25 to 72 years. The 
median age was 50 years with an interquartile range of 
43 to 58 years.
The 37.1% (43) of the total cases have category BI-RADS 
0, 6.9% (8) BI-RADS 1, 8.6% (10) BI-RADS 2, 7.8% (9) BI-
RADS 3, 28.4% (33) BI-RADS 4, 8.6% (10) BI-RADS 5 and 
2.6% (3) BI-RADS 6.
The composition of the breast was: almost entirely 
adipose tissue 8.6% (10), with scattered sectors of 
fibroglandular density 39.7% (46), heterogeneously 
dense 37.9% (44) and very dense 13.8% (16).
We detected 8 cases of breast cancer with suspicious 
calcifications and 3 controls detected with suspicious 
calcifications without malignancy. The histological 
strains found are infiltrating ductal carcinoma, 
ductal carcinoma in situ, and infiltrating lobular 
The most frequent suspicious calcifications in breast malignancy were amorphous and fine pleomorphic, both 
with 37.5% of cases.
Table 1. Characteristics of patients with mammographic calcifications suspected of malignancy.
Table 2. Frequency of calcifications suspected of malignancy. 
Age BIR-RADS Grade Diagnosis Calcification
58 4c Infiltrating ductal carcinoma Fine pleomorphic
55 4b




Infiltrating ductal carcinoma and ductal 
carcinoma in situ
 Fine pleomorphic
62 5 Infiltrating ductal carcinoma  Fine pleomorphic
50 5 Infiltrating ductal carcinoma
 Fine branching and fine  
pleomorphic
42 4c Infiltrating lobular carcinoma  Amorphous
72 5
Infiltrating ductal carcinoma and ductal 
carcinoma in situ
 Amorphous
45 0 Ductal carcinoma in situ Coarse heterogeneous 
49 4a Fibrocystic breast disease
 Suspicious 
microcalcifications
47 4b  Fibroadenoma  Fine pleomorphic
43 5  Fibroadenoma  Grouped amorphous 
carcinoma. The suspicious calcifications found were: 
amorphous, coarse heterogeneous, fine branching, 
fine pleomorphic and no specified. In relation to the 









Amorphous 2 1 0 3(37,5%)
Coarse 
heterogeneous              
0 0 1 1(12,5%)
Fine pleomorphic         3 0 0 3(37,5%)
Fine branching             1 0 0 1(12,5%)
Total     6 (75%) 1 (15%) 1 (15%) 8 (100%)













Table 3. Association between age at risk and breast cancer.
Table 4. Association between suspicious calcifications and breast cancer.  
Table 5. Association between BI-RADS grade and breast cancer.
Age at risk Breast cancer No breast cancer P value OR 95% CI




Over (47,5%)  of 50 years 31 (52,5%)
Biomedical
28 (47,5%)
Of those over 50 years 52.5% (31) had breast cancer 
and 47.5% (28) did not are carries of cancer. The odds 
The 72.7% (8) of patients with calcifications suspected 
of malignancy developed breast cancer, and 27.3% 
(3) did not have breast cancer. An odds ratio of 4.16 
DISCUSSION
Breast cancer is the most common cancer in women 
worldwide1. In Peru it is a public health problem since 
it has a high burden of disease and also generates 
high costs for its treatment(6). For this reason, knowing 
the factors that allow accurate diagnosis is of vital 
importance.
In our study, we found that the mean age of breast 
cancer patients was 54 years. Patients aged 50 years 
or older with breast cancer represented 63.3% of 
the total. This endorses and supports the American 
Cancer Society's recommendations for breast cancer 
screening. This suggests that women between the ages 
of 45 and 54 should have a mammogram annually(7). 
The incidence of this cancer in women in Peru is 40 per 
Patients with high-risk BI-RADS (categories 4, 5 and 6), 
54.3% (25) had breast cancer, compared with 29.6% of 
patients with low risk (categories 1, 2 and 3). An odds 
ratio of 2.83 95% CI (1.03-7.76) and a p value= 0.041 
were obtained, a significant association was found.
ratio was 2.40 95 % CI (1.13-5.11) with p = 0.022.
Calcifications suspected of 
malignancy
Breast cancer No breast cancer P value OR 95% CI




Yes (27,3%) 8 (72,7%)     
Biomedical
3 (27,3%)
95% CI (1.04-16.61) and p = 0.031 were obtained, a 
significant association was found.
Grade of BI-RADS Breast cancer No breast cancer P value OR 95% CI
Low risk (70,4%) 8 (29,6%)
Biomedical
19 (70,4%) 
0,041 2,83  1,03-7,76
High risk (45,7%) 25 (54,3%)
Biomedical
21 (45,7%)
In the multivariate analysis, the BI-RADS risk presented 
an OR of 1.21 95% CI (0.72-2.02) and p = 0.469, which 
was not significant. The over 50 years presented an OR 
of 2.54 95% CI (1.16-5.56), p = 0.020, while calcifications 
suspected of malignancy presented an OR of 4.44 (1.07-
18.37) and p = 0.040
100,000 inhabitants; However, the incidence between 
45 and 54 years is 95 per 100 0008.
The association between age and breast cancer is 
widely known and the trend is that the older the 
patient, the greater the cancer8. Regarding this 
variable, the study found that 52.5% of those older 
than 50 years were found inside breast cancer cases, 
which resulted in an odds ratio of 2.40 95% CI (1.13-
5.11) and p = 0.022 (< 0.05). This contrasts with the 
trend demonstrated by S. Eve Singletary(9) in "Rating 
the Risk Factors for Breast Cancer", where the incidence 
is extremely low in those under 30 years (incidence less 
than 25 per 100,000). But it increases linearly until the 
age of 80 years. The relative risk for women older than 
65 years compared to those younger than 65 years is 
5.8 in this study.













Regarding the grade of BI-RADS, in the present study 
54.3% of patients with high-risk BI-RADS (categories 
4, 5, and 6) were found to be inside breast cancer 
cases. An odds ratio of 2.827 (95% CI (1.03-7.758) and 
p = 0.041 were obtained, which reveals that having 
a high-risk BI-RADS (categories 4, 5 and 6) confers 
a risk of 2.8 times in relation to having a low-risk BI-
RADS (categories 1, 2, 3), was not considered grade 
0 because by definition it requires another more 
specialized mammographic test (amplification) 
or ultrasound to catalog it properly. The BI-RADS 
classification is developed by the American College 
of Radiology and, as mentioned, is the currently used 
tool to inform mammography(10). Its importance lies 
in the fact that through the description of lesions, the 
presence of malignancy in the patient is predicted, 
being a very useful tool for indicating biopsy. In the 
study by Chris Bent and colleagues(11), entitled: “The 
Positive Predictive Value of BI-RADS Microcalcification 
Descriptors and Final Assessment Categories”, it 
is found that the risk of malignancy according to 
BI-RADS categories increases progressively, the 
difference between each category (p< 0.001) and each 
subcategory (p< 0.001) are statistically significant, 
demonstrating that the radiologist can satisfactorily 
stratify the malignancy potential with BI-RADS. The 
positive predictive values for malignancy according 
to BI-RADS system were the following: category 2: 0%, 
category 3: 0%, category 4: 13%, category 4B: 36%, 
category 4C: 79%; And category 5, 100% in contrast 
to our work agrees that the higher the BI-RADS, 
the higher the risk of malignancy; However, due to 
statistical limitations, the logistic regression of BI-RADS 
categories and subcategories was not significant in 
the multivariate analysis.
The most common malignancy in our study is infiltrating 
ductal carcinoma (75%), followed by infiltrating 
lobular carcinoma (15%) and ductal carcinoma in situ 
(15%). Similar to this, it is observed in the result of the 
descriptive epidemiological study carried out from 1987 
to 1999 by Christopher Li and colleagues(12), entitled 
“Trends in Incidence Rates of Invasive Lobular and 
Ductal Breast Carcinoma”, where it was established that 
the most common histological type in breast cancer is 
the infiltrating ductal carcinoma type (72.8%) followed 
by infiltrating lobular carcinoma (7.6%) and infiltrating 
ductal carcinoma and infiltrating lobular carcinoma 
(4.7%) of a population of 190 458 cases.
In relation to the composition of the breast, it was 
found that those constituted by scattered sectors 
of fibroglandular density are the most frequent, 
followed by heterogeneously dense breasts. This 
contrasts with the study by Madiha Naseem and 
colleagues(13), in which are significantly associated (p = 
0.031), after evaluating 937 women, the calcifications 
suspected of malignancy with heterogeneous breast 
density to fibroglandular predominance. Our study 
found no statistical association with breast cancer or 
mammographic calcifications. Increased breast density 
is known to be a risk factor for breast cancer because it 
prevents the visualization of mammographic findings 
by decreasing sensitivity(14). Calcifications suspected of 
malignancy are grouped in this study and are shown 
to have a significant association with malignancy. It 
is observed that 72.7% of patients with calcifications 
suspected of malignancy are inside breast cancer 
cases. With p = 0.031 95% CI (1.04-16.61). Having 
this type of calcifications represents a risk about 4 
times higher compared to the group that does not 
have them. The characteristics of the calcifications 
are described according to the fifth edition of BI-
RADS(15); However, one of the controls was described 
as suspicious calcifications, a term partially correct, 
because the fact that it is suspicious does not mean 
that the type of calcification should not be described. 
In turn, the correlation of the presence of any type of 
suspicious calcification conditions a BI-RADS grade 
ranging from 4 to 5, and it is not coherent in the 
BI-RADS system to define a case with a suspicious 
calcification (coarse heterogeneous) as BI-RADS 0, an 
event that occurs in one of the controls of this study(16). 
The calcifications associated with malignancy were 
found in order of frequency: fine pleomorphic (37.5%), 
amorphous (37.5%), fine branching (12.5%) and 
coarse heterogeneous (12.5%). In the study, entitled 
“Mammographic microcalcifications and breast cancer 
tumorigenesis: a radiologic-pathologic analysis” 
associate the morphology with risk of malignancy 
(p <.001), being the fine branching the one that has 
greater risk of malignancy with 70%, followed by fine 
pleomorphic (28%), coarse heterogeneous (20%), and 
amorphous (20%)(11).
CONCLUSION
Mammographic calcifications suspected of 
malignancy were a factor strongly associated with the 
presence of breast cancer regardless of age and BI-
RADS classification.













Correspondence: Víctor Gabriel Arteaga Huanca.
Address: Avenida Perú 1680 San Martín de Porres, Lima-Perú.
Telephone: +993819417 
E-mail: victor_arteaga92@hotmail.com
Authorship Contributions: The authors participated 
in the conception, drafting and final approval of the 
original article, as well as VAH in data collection.
Financing: Self-financed.
Interest conflict: The authors declare no conflict of 
interest in the publication of this article.
Received: July 20, 2019
Approved: November 10, 2019
BIBLIOGRAPHIC REFERENCES  
1. Organización Mundial de la Salud. Nota descriptiva. Cáncer. Septiembre 2018. 
Disponible en: https://www.who.int/news-room/fact-sheets/detail/cancer  
2. Instituto Nacional de Enfermedades Neoplásicas. Casos nuevos de cáncer 
registrados en INEN, periodo 2000-2016. Disponible en: https://portal.inen.sld.pe/
wp-content/uploads/2018/06/INEN-CASOS-NUEVOS-2000-2016.pdf 
3. Warner E. Clinical practice. Breast-Cancer screening. N Engl Med. 2011. 
365(11):1025-32. DOI: 10.1056/NEJMcp1101540
4. Instituto Nacional de Estadística e Informática. Programa de prevención y control 
del cáncer. Perú, enfermedades no trasmisibles y transmisibles. Lima-Perú. 2016. 
p. 83 - 94. Disponible en: www.inei.gob.pe/media/MenuRecursivo/publicaciones_
digitales/Est/Lib1432/cap02.pdf 
5. Poquioma E. Situación del cáncer de mama en el Perú. Departamento de 
Epidemiologia y Estadística del INEN. 2008. Disponible en: http://bvsper.paho.org/
videosdigitales/matedu/20111205_Cancer_Mama_Epi.pdf?ua=1 
6. Oeffinger KC, Fontham ETH, Etzioni R, et al. Breast Cancer Screening for Women 
at Average Risk: 2015 Guideline Update from the American Cancer Society. JAMA. 
2015;314(15):1599-1614. doi:10.1001/jama.2015.12783
7. World Health Organization. Breast Global Cancer Observatory. Globocan 2018. 
Disponible en: https://gco.iarc.fr/today/data/factshetts/cancer/20-Breast-fact-
sheet.pdf 
8. Singletary S. E. Rating the Risk Factors for Breast Cancer. Annals of Surgery. 
2003; 237(4): 474–82. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC1514477/pdf/20030400s00007p474.pdf 
9. American College of Radiology. BI-RADS. Sistema de informes y registro de 




10. Chris K, Lawrence W, Carl Ji, James W. The Positive Predictive Value of BI-RADS 
Microcalcification Descriptors and Final Assessment Categories. American Journal 
of Radiology, may 2010; 194(5): 1378–83. DOI: 10.2214/AJR.09.3423.
11. Li CI, Anderson BO, Daling JR, Moe RE: Trends in incidence rates of invasive 
lobular and ductal breast carcinoma. JAMA 2003; 289(11):1421-24. DOI: 10.1001/
jama.289.11.1421 
12. Naseem M, Murray J, Hilton J F, et al. Mammographic microcalcifications and 
breast cancer tumorigenesis: a radiologic-pathologic analysis. BMC Cancer.2015; 
15:307. DOI: 10.1186/s12885-015-1312-z.
13. Kennedy G, Markert M, Alexander JR, Avisar E. Predictie value of BI-RADS 
classification for breast imaging in women under age 50. Breast Cancer Research 
and Treatment. 2011; 130(3):819-23. doi: 10.1007/s10549-011-1669-x.
14. Spak D.A. Plaxco J.S. Santiago L. Drydenb M.J. Dogan B.E. BI-RADS fifth edition: 
A summary of changes.Diagn Intery Imaging. 2017;98(3): 179-90. DOI: 10.1016/j.
diii.2017.01.001
15. Rominger M, Wisgickl C and Timmesfeld N. Breast microcalcifications as type 
descriptors to stratify risk of malignancy: a systematic review and meta-analysis 
of 10665 cases with special focus on round/punctate microcalcifications. RöFo. 
2012;184(12):1144-52. DOI: 10.1055/s-0032-1313102.




Enero - Marzo 2020
Indexed in:
https://alicia.concytec.gob.pe/vufind/
